Register today for the next NOS meeting on May 10th!
---------------------------------------
Registration also open now for the 13th Annual ASCO Review
**June 16th, 2012 (click link above to register)
-----------------------------
Thank you to everyone who attended the recent GU/Prostate Oncology Update! Thank you to our great speakers and also to our vendors for supporting the event!
-----------------------------------------------------
WELCOME NEW CORPORATE MEMBERS!
NOS is pleased to welcome TEVA and SEATTLE GENETICS to the NOS! Please thank all of our corporate member representatives when you see them! We look forward to working with you this year! For more information & to see a complete list of NOS Corporate Members please visit the Corporate Membership page (see tab on the left)
Corporate Member Genentech released New Drug:
ERIVEDGE (vismodegib) capsule for metastatic basal cell cancer (2/2012).
Corporate Member Pfizer released new drug: INLYTA (Axitinib) for advanced renal cell cancer after progression on one systemic treatment (1/2012).
